Carvedilol, a new non-selective beta-blocker with intrinsic anti alpha adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

被引：0
|
作者：
Banares, R
GarciaPagan, JC
Piqueras, B
Casado, M
Moitinho, E
deDiego, A
Escorsell, A
Bandi, J
Cos, E
Bosch, J
机构：
[1] H GREGORIO MARANON,HEPAT HEMODYNAM LABS,MADRID,SPAIN
[2] H CLIN,BARCELONA,SPAIN
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 11 条
  • [1] Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
    Bañares, R
    Moitinho, E
    Piqueras, B
    Casado, M
    García-Pagán, JC
    de Diego, A
    Bosch, J
    HEPATOLOGY, 1999, 30 (01) : 79 - 83
  • [2] Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension
    Turco, Laura
    Reiberger, Thomas
    Vitale, Giovanni
    La Mura, Vincenzo
    LIVER INTERNATIONAL, 2023, 43 (06) : 1183 - 1194
  • [3] COMPARISON OF THE EFFECTS OF A CARDIOSELECTIVE BETA-BLOCKER AND OF A NON-SELECTIVE BETA-BLOCKER ON THE PORTAL PRESSURE IN PATIENTS AFFLICTED WITH CIRRHOSIS
    HILLON, P
    LEBREC, D
    MUNOZ, C
    GOLDFARB, G
    BENHAMOU, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1981, 5 (12): : 1185 - 1185
  • [4] COMPARISON OF THE EFFECTS OF A CARDIOSELECTIVE AND A NON-SELECTIVE BETA-BLOCKER ON PORTAL-HYPERTENSION IN PATIENTS WITH CIRRHOSIS
    HILLON, P
    LEBREC, D
    MUNOZ, C
    JUNGERS, M
    GOLDFARB, G
    BENHAMOU, JP
    HEPATOLOGY, 1982, 2 (05) : 528 - 531
  • [5] COMPARISON OF THE EFFECTS OF A CARDIOSELECTIVE AND A NON-SELECTIVE BETA-BLOCKER ON PORTAL-HYPERTENSION IN PATIENTS WITH CIRRHOSIS
    LEBREC, D
    HILLON, P
    MUNOZ, C
    JUNGERS, M
    GOLDFARB, G
    BENHAMOU, JP
    HEPATOLOGY, 1982, 2 (01) : 155 - 155
  • [6] Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure
    Zaikin, SY
    Iosava, IK
    Vasechkin, SS
    Gruzdev, AK
    Sidorenko, BA
    KARDIOLOGIYA, 2002, 42 (04) : 33 - 36
  • [7] The effect of long-term use of non-selective beta-blocker on the development of acute kidney injury in patients with liver cirrhosis
    Kim, Sang Gyune
    Kim, W. Ray
    Larson, Joseph J.
    Kremers, Walter K.
    Kamath, Patrick S.
    HEPATOLOGY, 2014, 60 : 277A - 278A
  • [8] Non-selective beta-blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real-world study
    Kumar, Rahul
    Lin, Su
    Mehta, Gautam
    Mesquita, Monica D.
    Calvao, Joana A. F.
    Sheikh, M. Faisal
    Agarwal, Banwari
    Mookerjee, R. P.
    Jalan, Rajiv
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 907 - 920
  • [9] BLOOD-PRESSURE AND HEART-RATE DURING SUSTAINED HANDGRIP IN HYPERTENSIVE PATIENTS TAKING PLACEBO, A NON-SELECTIVE BETA-BLOCKER (PROPRANOLOL), AND A SELECTIVE BETA-1-BLOCKER (METOPROLOL)
    NYBERG, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 22 (06): : 828 - 838
  • [10] The association of non-selective beta-blocker use and acute kidney injury in patients with decompensated cirrhosis admitted into hospital - A Study from the North American Consortium for the Study of End Stage Liver Diseae (NACSELD)
    Wong, Florence
    O'Leary, Jacqueline G.
    Reddy, K. Rajender
    Garcia-Tsao, Guadalupe
    Biggins, Scott W.
    Fallon, Michael B.
    Tandon, Puneeta
    Subramanian, Ram M.
    Maliakkal, Benedict
    Thuluvath, Paul J.
    Vargas, Hugo E.
    Kamath, Patrick S.
    Thacker, Leroy
    Bajaj, Jasmohan S.
    HEPATOLOGY, 2015, 62 : 250A - 250A
12